[go: up one dir, main page]

WO2020124430A1 - 一种可持续灌注引流管 - Google Patents

一种可持续灌注引流管 Download PDF

Info

Publication number
WO2020124430A1
WO2020124430A1 PCT/CN2018/122070 CN2018122070W WO2020124430A1 WO 2020124430 A1 WO2020124430 A1 WO 2020124430A1 CN 2018122070 W CN2018122070 W CN 2018122070W WO 2020124430 A1 WO2020124430 A1 WO 2020124430A1
Authority
WO
WIPO (PCT)
Prior art keywords
drainage
tube
cavity
perfusion
tube body
Prior art date
Application number
PCT/CN2018/122070
Other languages
English (en)
French (fr)
Inventor
汪郁卉
张世忠
杜晨晓
李午阳
Original Assignee
深圳市擎源医疗器械有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳市擎源医疗器械有限公司 filed Critical 深圳市擎源医疗器械有限公司
Priority to PCT/CN2018/122070 priority Critical patent/WO2020124430A1/zh
Publication of WO2020124430A1 publication Critical patent/WO2020124430A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use

Definitions

  • the invention belongs to the technical field of medical devices, and more specifically, relates to a sustainable perfusion drainage tube.
  • hypertensive cerebral hemorrhage In today's society, people's unhealthy lifestyle, increased stress in life and lack of exercise, etc., have led to hypertensive cerebral hemorrhage has become a common disease and frequent incidence. The disease has three characteristics: high morbidity, high mortality, and high disability. And hypertensive cerebral hemorrhage, about 80% of its intracranial hemorrhage occurs in the basal ganglia area, and the basal ganglia area is the area where important nerve central conductive fibers pass through. Therefore, hypertensive cerebral hemorrhage often causes the patient to die or die. Therefore, the effective treatment of hypertensive intracerebral hemorrhage with reasonable medical equipment is of great significance.
  • craniotomy was used to treat hypertensive cerebral hemorrhage in clinical practice. Because of the need for craniotomy, the brain tissue will be damaged to varying degrees while removing the hematoma in the brain.
  • minimally invasive surgical treatment that is, the use of craniocerebral drainage tube for intracranial hematoma puncture and drainage
  • this method can not only quickly drain out of the brain hematoma, but also will not cause additional damage to brain tissue And, it has the advantages of fast recovery, low cost, and easy recovery of brain function of patients. Therefore, this method has been widely used.
  • single-tube single-lumen drainage tubes have been difficult to meet the patients' needs for drainage effects.
  • a sustainable perfusion drainage tube is provided to solve the technical problems of the drainage tube with a small drainage cavity and a low drainage rate in the prior art.
  • a medical drainage tube including a tube body and a rear cannula communicating with the tube body and located at the rear end of the tube body, the tube body having mutually isolated drainage cavities and perfusion along its length Cavity, the rear cannula includes a first branch tube communicating with the drainage cavity and a second branch tube communicating with the perfusion cavity, the front end of the tube body is provided with a plurality of outlets communicating with the perfusion cavity For the liquid port, the side wall of the tube body is further provided with a drainage port communicating with the drainage cavity, and there is a gap between the drainage port and the plurality of liquid outlets.
  • the beneficial effect of the sustainable perfusion drainage tube is that, compared with the drainage tube of the single tube and multiple sub-tubes in the prior art, a mutually isolated drainage cavity is provided in the tube body and Perfusion chamber, to achieve independent drainage and perfusion, it can have a larger drainage chamber under the same diameter, improve the drainage rate, reduce the risk of tube blockage, and have more drainage chambers than existing drainage pipes when the drainage chamber has a similar cross-section
  • the small diameter can reduce the compression of brain tissue and reduce trauma; at the front end of the tube body, multiple points of drug delivery are achieved through multiple liquid outlets that communicate with the perfusion cavity, increasing the contact area between the drug and the hematoma, and efficiently dissolving the hematoma, while
  • the continuous perfusion through the perfusion cavity increases the contact time between the drug and the hematoma compared with one-time administration.
  • the reaction is conducive to exerting the drug effect, improving the dissolution rate, shortening the drainage tube retention time, reducing the risk of puncture
  • FIG. 1 is a schematic structural diagram of a sustainable perfusion provided by an embodiment of the present invention
  • FIG. 2 is a schematic structural diagram of a second sustainable infusion provided by an embodiment of the present invention.
  • a component when referred to as being “fixed” or “disposed on” another component, it can be directly on the other component or indirectly on the other component.
  • a component When a component is said to be “connected to” another component, it can be directly connected to the other component or indirectly connected to the other component.
  • first and second are used for description purposes only, and cannot be understood as indicating or implying relative importance or implicitly indicating the number of indicated technical features.
  • features defined as “first” and “second” may explicitly or implicitly include one or more of the features.
  • the meaning of “plurality” is two or more, unless otherwise specifically limited.
  • a sustainable perfusion drainage tube provided by Embodiment 1 of the present invention includes a tube body 10 and a rear cannula communicating with the tube body 10 and located at the rear end of the tube body 10, and the tube body 10 is isolated from each other along its length
  • the drainage cavity 11 and the perfusion cavity 12 the rear cannula includes a first branch tube 20 communicating with the drainage cavity 11 and a second branch tube 30 communicating with the perfusion cavity 12, the front end of the tube body 10 is provided with a plurality of communicating with the perfusion cavity 12
  • the side wall of the tube body 10 is further provided with a drainage port 13 communicating with the drainage chamber 11, and there is a gap between the drainage port 13 and the plurality of liquid outlets 40.
  • a drainage cavity 11 and a perfusion cavity 12 that are isolated from each other are provided in the tube body 10 to achieve independent drainage and perfusion, which can be at the same diameter It has a larger drainage cavity 11 under the condition of increasing the drainage rate and reducing the risk of clogging.
  • the drainage cavity 11 has a comparable cross-section, it has a smaller diameter than the existing drainage tube, which can reduce the crowding of brain tissue.
  • the distance there is a certain distance between the drainage port 13 and the closest liquid outlet 40, and the distance may be 15 mm-20 mm.
  • the plurality of liquid outlets 40 include a plurality of first liquid outlets 41 located at the front end of the pipe body 10 and a plurality of second liquid outlets 42 located at the front end side wall of the pipe body 10.
  • the plurality of first liquid outlets 41 are distributed in a divergent manner; the plurality of second liquid outlets 42 are distributed at multiple points along the length of the front end, and are evenly distributed along the circumferential direction.
  • the plurality of first liquid outlets 41 and the plurality of second liquid outlets 42 continuously administer multiple parts of the hematoma from multiple directions, thereby improving the efficiency of dissolution and drainage of the hematoma.
  • first branch pipe 20 is also provided with a luer connector (not shown in the figure) for connecting an external conduit.
  • the first branch tube 20 is connected to an external drainage line through a luer connector, and collects the hematoma into a sterile drainage bag.
  • the end of the second branch tube 30 is also provided with a heparin cap 31.
  • the second branch tube 30 is connected to the infusion device through the heparin cap 31, and the medicine of the infusion device is continuously delivered to the hematoma site through the infusion chamber 12 and the liquid outlet 40, thereby improving the hemolysis dissolution efficiency.
  • first branch pipe 20 and the second branch pipe 30 are connected together by a pipe joint 50.
  • the first branch pipe 20 and the second branch pipe 30 are effectively fixed by the pipe joint 50, which is convenient for operation during the operation.
  • the sustainable perfusion drainage tube provided in the embodiment of the present invention is different from the sustainable perfusion drainage tube in the first embodiment in that a balloon cavity 14 is further provided in the tube body 10.
  • the perfusion chamber 12 is arranged in parallel, and a positioning balloon 15 for communicating with the balloon cavity 14 is also provided at the front end of the tube body 10, and the rear cannula further includes a third branch tube 60 communicating with the balloon cavity 14
  • the third branch pipe 60 is provided with a check valve 61.
  • the drainage tube is generally left for 5-7 days according to the hematoma removal situation.
  • the care during the drainage process is particularly critical to prevent the drainage tube from coming out.
  • an appropriate amount of saline is injected into the one-way valve 61 with a syringe to make the saline pass through the balloon cavity 14 to reach the positioning balloon 15 to inflate the positioning balloon 15 to drain
  • the tube is fixed in the sulcus of the brain tissue, so as to fix the drainage tube, avoid the drainage tube from falling out, and reduce the risk of infection or reintubation.
  • the diameter of the positioning balloon 15 after the liquid is injected is in the range of 15mm-20mm.
  • an indicator balloon 62 is also provided on the third branch tube 60, and the indicator balloon 62 communicates with the positioning balloon 15 to monitor whether the positioning balloon 15 is leaking, etc., to reduce the risk of the drainage tube coming out.
  • the first branch pipe 20, the second branch pipe 30, and the third branch pipe 60 are connected together by a pipe joint 50.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • External Artificial Organs (AREA)

Abstract

一种可持续灌注引流管，包括管体(10)以及与管体(10)连通且位于管体(10)后端的后插管，管体(10)内沿其长度方向具有相互隔离的引流腔(11)及灌注腔(12)，后插管包括与引流腔(11)连通的第一分支管(20)以及与灌注腔(12)连通的第二分支管(30)，管体(10)的前端设有多个与灌注腔(12)连通的出液口(40)，管体(10)的侧壁上还设有与引流腔(11)连通的引流口(13)，引流口(13)与多个出液口(40)之间具有间距。本发明中，相较于现有技术中的单管多子管的引流管，在管体(10)内设置相互隔离的引流腔(11)及灌注腔(12)，实现引流和灌注独立，可在同等直径的条件下具有更大的引流腔(11)，提高引流速率，降低堵管风险，在距离出液口（40）一定间距处设置引流口（13），使得药物持续灌注、充分与血肿反应，利于发挥药效。

Description

一种可持续灌注引流管 技术领域
本发明属于医疗器械技术领域，更具体地说，是涉及一种可持续灌注引流管。
 背景技术
现在社会中，人们不健康的生活方式，生活压力的增加以及缺乏运动等多种原因，导致高血压性脑出血已成为一种常见病及多发病。该病具有高发病率、高死亡率、高致残率的三高特点。而且高血压性脑出血，其颅内出血部位约80％发生在基底节区，而基底节区为重要神经中枢传导纤维通过的区域，因此，高血压性脑出血常造成病人不死即残的状况，所以，利用合理的医疗器械进行高血压性脑出血的有效治疗具有非常重要的意义。
以往临床对于高血压性脑出血疾病，多采用开颅手术方式进行治疗，这种方式由于需要开颅，手术中在清除脑内血肿的同时，会不同程度的造成脑组织的损伤。近年来，临床上多采用微创手术方式进行治疗，即使用颅脑引流管进行颅内血肿穿刺引流，该方法不仅可以迅速地将脑内血肿引流出来，也不会造成对脑组织的额外损伤，并具有病人恢复快、费用低、病人脑功能容易恢复等优势，因此，该方法得到了广泛的应用。
随着手术方式以及引流手术器械的发展，单管单腔引流管已难以满足病患对引流效果的需求。随即出现了单管多腔以及单管多子管等引流管，如有的引流管通过在总管中设置多个子管，并通过在总管前部设置子管伸缩孔，使得子管可以伸出或缩回到总管中，当子管前部伸出总管时，可实现多点给药引流，从而加快血凝块的溶解和引流速度，进而快速解除血肿对于主要功能结构的压迫，降低高血压脑出血疾病造成的危害。
但是这种引流管由于具有多点给药的多个子管，在外径尺寸相当的情况下势必会牺牲引流腔直径，导致引流速率下降，提升堵管风险。同时，注入药物需要与血肿有一定的反应时间，药物还未与血凝块充分反应便从引流口引出，影响血凝块的溶解和引流速率，多次的人工给药又会带来感染风险。
 技术问题
本发明实施例的目的在于：第一方面，提供一种可持续灌注引流管，用以解决现有技术中引流管引流腔小，引流速率低的技术问题。
 技术解决方案
为解决上述技术问题，本发明实施例采用的技术方案是：
第一方面，提供了一种医用引流管，包括管体以及与所述管体连通且位于所述管体后端的后插管，所述管体内沿其长度方向具有相互隔离的引流腔及灌注腔，所述后插管包括与所述引流腔连通的第一分支管以及与所述灌注腔连通的第二分支管，所述管体的前端设有多个与所述灌注腔连通的出液口，所述管体的侧壁上还设有与所述引流腔连通的引流口，所述引流口与多个所述出液口之间具有间距。
 有益效果
与现有技术相比，本发明实施例提供的可持续灌注引流管的有益效果在于：相较于现有技术中的单管多子管的引流管，在管体内设置相互隔离的引流腔及灌注腔，实现引流和灌注独立，可在同等直径的条件下具有更大的引流腔，提高引流速率，降低堵管风险，且在引流腔横截面相当的情况下比现有的引流管具有更小的直径，能减轻对脑组织的挤压，减小创伤；在管体前端通过与灌注腔连通的多个出液口实现多点给药，增加药物与血肿接触面积，高效溶解血肿，同时，通过灌注腔持续进行灌注相比一次性给药增加药物与血肿的接触时间，更加有效的溶解血肿，利于引出体外；同时，在距离出液孔一定间距处设置引流口，使得药物充分与血肿反应，利于发挥药效，提高溶解速率，缩短引流管留置时间，减小穿刺感染风险，对预后也有积极意义。
 附图说明
为了更清楚地说明本发明实施例中的技术方案，下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍，显而易见地，下面描述中的附图仅仅是本发明的一些实施例，对于本领域普通技术人员来讲，在不付出创造性劳动的前提下，还可以根据这些附图获得其它的附图。
图1为本发明实施例提供一的可持续灌注的结构示意图；
图2为本发明实施例提供二的可持续灌注的结构示意图；
其中，图中各附图标记：
10-管体；11-引流腔；12-灌注腔；13-引流口；14-球囊腔；15-定位球囊；20-第一分支管；30-第二分支管；31-肝素帽；40-出液口；41-第一出液口；42-第二出液口；50-管接头；60-第三分支管；61-单向阀；62-指示气囊。
 本发明的实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合附图及实施例，对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅用以解释本发明，并不用于限定本发明。
需说明的是，当部件被称为“固定于”或“设置于”另一个部件，它可以直接在另一个部件上或者间接在该另一个部件上。当一个部件被称为是“连接于”另一个部件，它可以是直接连接到另一个部件或者间接连接至该另一个部件上。
还需说明的是，本发明实施例的附图中相同或相似的标号对应相同或相似的部件；在本发明的描述中，需要理解的是，若有术语“上”、“下”、“左”、“右”等指示的方位或位置关系为基于附图所示的方位或位置关系，仅是为了便于描述本发明和简化描述，而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作，因此，附图中描述位置关系的用语仅用于示例性说明，不能理解为对本专利的限制，对于本领域的普通技术人员而言，可以根据具体情况理解上述术语的具体含义。
此外，术语“第一”、“第二”仅用于描述目的，而不能理解为指示或暗示相对重要性或者隐含指明所指示的技术特征的数量。由此，限定有“第一”、“第二”的特征可以明示或者隐含地包括一个或者更多该特征。在本发明的描述中，“多个”的含义是两个或两个以上，除非另有明确具体的限定。
为了说明本发明所述的技术方案，以下结合具体附图对本发明提供的一种可持续灌注引流管的实现通过具体实施例进行详细说明。
实施例一
参照图1，本发明实施例一提供的可持续灌注引流管，包括管体10以及与管体10连通且位于管体10后端的后插管，管体10内沿其长度方向具有相互隔离的引流腔11及灌注腔12，后插管包括与引流腔11连通的第一分支管20以及与灌注腔12连通的第二分支管30，管体10的前端设有多个与灌注腔12连通的出液口40，管体10的侧壁上还设有与引流腔11连通的引流口13，引流口13与多个出液口40之间具有间距。
本发明实施例中，相较于现有技术中的单管多子管的引流管，在管体10内设置相互隔离的引流腔11及灌注腔12，实现引流和灌注独立，可在同等直径的条件下具有更大的引流腔11，提高引流速率，降低堵管风险，且在引流腔11横截面相当的情况下比现有的引流管具有更小的直径，能减轻对脑组织的挤压，减小创伤；在管体10前端通过与灌注腔12连通的多个出液口40实现多点给药，增加药物与血肿接触面积，高效溶解血肿，同时，通过灌注腔12持续进行灌注相比一次性给药增加药物与血肿的接触时间，更加有效的溶解血肿，利于引出体外；同时，在距离出液孔一定间距处设置引流口13，使得药物充分与血肿反应，利于发挥药效，提高溶解速率，缩短引流管留置时间，减小穿刺感染风险，对预后也有积极意义。
进一步地，本实施例中，引流口13与距离最近的出液口40之间有一定的间距，间距可为15mm-20mm。通过对引流口13位置的上述设置，使得药物进入血肿部位能与血肿有充分的作用时间，达到溶解血肿的目的，然后再由引流口13引出体外。
具体地，多个出液口40包括位于管体10的前端端部的多个第一出液口41以及位于管体10的前端侧壁的多个第二出液口42。多个第一出液口41呈发散状分布；多个第二出液口42沿前端长度方向多点分布，同时沿周向均匀分布。通过多个第一出液口41与多个第二出液口42从多个方向对血肿的多个部位进行持续给药，提高血肿溶解引流效率。
进一步地，第一分支管20端部还设有用于连接外部导管的鲁尔接头（图中未示出）。第一分支管20通过鲁尔接头连接到外部引流管路上，将血肿收集到无菌的引流袋中。
进一步地，第二分支管30端部还设有肝素帽31。第二分支管30通过肝素帽31接入灌注器，灌注器的药物通过灌注腔12、出液口40持续输送到血肿部位，提升血肿溶解效率。
本实施例中，引流口13为一个，当然，引流口13也可以为两个，或更多。当引流口13为两个或更多时，多个引流口13沿管体10长度方向间隔设置。
本实施例中，第一分支管20与第二分支管30通过管接头50连接于一体。通过管接头50将第一分支管20与第二分支管30进行有效固定，便于手术时操作。
实施例二
参照图2，本发明实施例提供的可持续灌注引流管与实施例一中可持续灌注引流管的不同之处在于，管体10内还设有球囊腔14，球囊腔14与引流腔11、灌注腔12平行设置，在管体10的前端还设有与球囊腔14连通用于注入液体的定位球囊15，后插管还包括与球囊腔14连通的第三分支管60，第三分支管60上设有单向阀61。
引流管根据血肿清除情况一般会留置5-7天，在引流过程中的护理，防止引流管脱出尤为关键。本实施例中，当引流管穿刺到位后，用注射器向单向阀61内注入适量生理盐水，使生理盐水通过球囊腔14到达定位球囊15，使定位球囊15充盈起来，从而将引流管固定在脑组织沟回处，从而起到固定引流管的作用，避免引流管脱出，降低感染或重新插管等风险。
具体地，定位球囊15注入液体后的直径范围为15mm-20mm。
进一步地，在第三分支管60上还设有指示气囊62，指示气囊62与定位球囊15连通，可监测定位球囊15是否出现泄漏等，降低引流管脱出风险。
本实施例中，为了便于固定，第一分支管20、第二分支管30及第三分支管60通过管接头50连接于一体。
另外，本实施例中，引流口13为两个，两个引流口13沿管体10长度方向间隔设置。
本实施例的其他结构与实施例一相同，此处不作赘述。
以上仅为本发明的优选实施例而已，并不用于限制本发明。对于本领域的技术人员来说，本发明可以有各种更改和变化。凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的权利要求范围之内。

Claims (10)

  1. 一种可持续灌注引流管，包括管体以及与所述管体连通且位于所述管体后端的后插管，其特征在于，所述管体内沿其长度方向具有相互隔离的引流腔及灌注腔，所述后插管包括与所述引流腔连通的第一分支管以及与所述灌注腔连通的第二分支管，所述管体的前端设有多个与所述灌注腔连通的出液口，所述管体的侧壁上还设有与所述引流腔连通的引流口，所述引流口与多个所述出液口之间具有间距。
  2. 根据权利要求1所述的可持续灌注引流管，其特征在于，所述引流口与距离最近的出液口之间的间距为15mm-20mm。
  3. 根据权利要求1所述的可持续灌注引流管，其特征在于，多个所述出液口包括位于所述管体的前端端部的多个第一出液口以及位于所述管体的前端侧壁的多个第二出液口。
  4. 根据权利要求3所述的可持续灌注引流管，其特征在于，多个所述第一出液口呈发散状分布；多个所述第二出液口沿所述管体长度方向多点分布，且沿周向均匀分布。
  5. 根据权利要求1所述的可持续灌注引流管，其特征在于，所述第一分支管端部还设有用于连接外部导管的鲁尔接头。
  6. 根据权利要求1所述的可持续灌注引流管，其特征在于：所述第二分支管端部还设有肝素帽。
  7. 根据权利要求1所述的可持续灌注引流管，其特征在于：所述引流口至少为两个，至少两个所述引流口沿所述管体长度方向间隔设置。
  8. 根据权利要求1至7任一项所述的可持续灌注引流管，其特征在于：还包括设于所述管体内且与所述引流腔及所述灌注腔平行的球囊腔，所述管体的前端还设有与所述球囊腔连通用于注入液体的定位球囊，所述后插管还包括与所述球囊腔连通的第三分支管，所述第三分支管上设有指示气囊和单向阀。
  9. 根据权利要求8所述的可持续灌注引流管，其特征在于：所述第三分支管上还设置有透明的指示气囊，所述指示气囊与所述的定位球囊连通。
  10. 根据权利要求8所述的可持续灌注引流管，其特征在于：所述第一分支管、所述第二分支管及所述第三分支管通过管接头连接于一体。
PCT/CN2018/122070 2018-12-19 2018-12-19 一种可持续灌注引流管 WO2020124430A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/122070 WO2020124430A1 (zh) 2018-12-19 2018-12-19 一种可持续灌注引流管

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/122070 WO2020124430A1 (zh) 2018-12-19 2018-12-19 一种可持续灌注引流管

Publications (1)

Publication Number Publication Date
WO2020124430A1 true WO2020124430A1 (zh) 2020-06-25

Family

ID=71100606

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/122070 WO2020124430A1 (zh) 2018-12-19 2018-12-19 一种可持续灌注引流管

Country Status (1)

Country Link
WO (1) WO2020124430A1 (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2306018Y (zh) * 1997-07-08 1999-02-03 黄卫东 前列腺灌注引流导管
CN101674860A (zh) * 2007-05-01 2010-03-17 宙迪璐企业有限公司 导管

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2306018Y (zh) * 1997-07-08 1999-02-03 黄卫东 前列腺灌注引流导管
CN101674860A (zh) * 2007-05-01 2010-03-17 宙迪璐企业有限公司 导管

Similar Documents

Publication Publication Date Title
CN111330138A (zh) 一种可持续灌注引流管
CN112914677B (zh) 一种用于血管溶栓的双球囊注射导管器械
CN110038209B (zh) 一种用于神经外科三叉神经经皮治疗的球囊扩张装置
CN110787339B (zh) 一种防静脉回流留置针
CN209713966U (zh) 一种可持续灌注引流管
CN210811354U (zh) 一种血栓清除导管系统
WO2020124430A1 (zh) 一种可持续灌注引流管
CN206577230U (zh) 一次性使用子宫填塞球囊导管
CN202446639U (zh) Picc抗返流穿刺针
CN201755226U (zh) 一种左右心房联合测压管
CN216908898U (zh) 药物输送用多腔式微导管
CN210844499U (zh) 一种体外置入式胸腹双腔冲洗引流管道装置
CN211245114U (zh) 一种硬脑膜外血肿清除装置
WO2019017817A1 (ru) Устройство для консервативной терапии заболеваний носа и околоносовых синусов
CN208114912U (zh) 一种y型两用双腔两囊引流器
CN219251117U (zh) 一种双腔颅内引流管
CN107088257B (zh) 一种y型两用双腔两囊引流器
CN202497589U (zh) 改良双腔引流管
CN209475232U (zh) 复合型颈部脓肿的经皮穿刺负压引流冲洗装置
CN209734064U (zh) 一种咽腔管
CN220608806U (zh) 一种新型静脉导管
CN217660977U (zh) 一种双腔picc导管封管用注射器
CN220090063U (zh) 一次性使用可注药防逆流无菌引流装置
CN214633180U (zh) 一种便捷式导尿管
CN211096558U (zh) 一种新型颌面颈部伤口滴注引流装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18944023

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18944023

Country of ref document: EP

Kind code of ref document: A1